CPIX — Cumberland Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $127.21m
- $123.01m
- $44.52m
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM
U.S. STOCKS ON THE MOVE-Netflix, J.B. Hunt, Arxis
U.S. STOCKS ON THE MOVE-Abbott, J.B. Hunt, Myseum
Cumberland Pharma rises after FDA approves broader use of pain drug
Cumberland Pharmaceuticals 2025 revenue rises
U.S. STOCKS ON THE MOVEx-IDEX Corp, Union Pacific, Qualcomm
U.S. STOCKS ON THE MOVE-CDW, Destiny Tech100, Avery Dennison
Cumberland jumps as heart drug for muscle‑wasting disease gets FDA's fast-track tag
Brief: Cumberland Pharmaceuticals Receives FDA Fast Track Designation For Its Ifetroban Duchenne Muscular Dystrophy Program
Cumberland Pharmaceuticals' Q3 revenue declines to $8.3 mln
Brief: CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO
Commercialization Partnership Deal
Brief: Cumberland Pharmaceuticals Ibuprofen Injection Product Approved In Mexico
Cumberland Pharma's Q2 revenue rises 10% yr/yr
Brief: Cumberland Pharmaceuticals Receives Vizient Contract For New Vibativ® 4-Vial Starter Pak